Roche's Ventana Licenses p63 Technology to Biocare | GenomeWeb

NEW YORK (GenomeWeb News) – Roche's Ventana Medical Systems today announced a non-exclusive licensing deal with Biocare Medical covering the p63 gene.

The deal is in parallel with a settlement agreement reached by Biocare and AsymmetRx Medical, which sued Biocare in 2007 alleging patent infringement related to the p63 technology.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Science this week: metagenomic-based technique for determining protein structure, and more.

An academic laments the rise of narcissism in the sciences, the Guardian reports.

Outgoing FDA commissioner Robert Califf writes in an editorial that the agency can help boost innovation.

The Trump transition team has asked NIH Director Francis Collins to remain at his post, though it's unclear for how long that will be.